HEADER SIGNALING PROTEIN 21-NOV-19 6THW TITLE IRAK4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS IRAK4, KINASE, INHIBITOR, CANCER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,A.AAGAARD,S.L.DEGORCE REVDAT 2 04-NOV-20 6THW 1 JRNL REVDAT 1 28-OCT-20 6THW 0 JRNL AUTH S.L.DEGORCE,A.AAGAARD,R.ANJUM,I.A.CUMMING,C.R.DIENE, JRNL AUTH 2 C.FALLAN,T.JOHNSON,K.J.LEUCHOWIUS,A.L.ORTON,S.PEARSON, JRNL AUTH 3 G.R.ROBB,A.ROSEN,G.B.SCARFE,J.S.SCOTT,J.M.SMITH,O.R.STEWARD, JRNL AUTH 4 I.TERSTIEGE,M.J.TUCKER,P.TURNER,S.D.WILKINSON,G.L.WRIGLEY, JRNL AUTH 5 Y.XUE JRNL TITL IMPROVING METABOLIC STABILITY AND REMOVING ALDEHYDE OXIDASE JRNL TITL 2 LIABILITY IN A 5-AZAQUINAZOLINE SERIES OF IRAK4 INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 28 15815 2020 JRNL REFN ESSN 1464-3391 JRNL PMID 33091850 JRNL DOI 10.1016/J.BMC.2020.115815 REMARK 2 REMARK 2 RESOLUTION. 2.44 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.44 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 25789 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.241 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1284 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.44 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.54 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.61 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2747 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2371 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2616 REMARK 3 BIN R VALUE (WORKING SET) : 0.2361 REMARK 3 BIN FREE R VALUE : 0.2567 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.77 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 131 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4397 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 148 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 69.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 82.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -11.44790 REMARK 3 B22 (A**2) : -4.03920 REMARK 3 B33 (A**2) : 15.48710 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.400 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.478 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.278 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.468 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.280 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.918 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4553 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6149 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1617 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 135 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 656 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4553 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 586 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5169 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.26 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.12 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.79 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -26.6306 -24.3506 -16.5959 REMARK 3 T TENSOR REMARK 3 T11: -0.0967 T22: -0.1626 REMARK 3 T33: -0.3040 T12: 0.1520 REMARK 3 T13: -0.0293 T23: -0.0263 REMARK 3 L TENSOR REMARK 3 L11: 2.3097 L22: 2.1472 REMARK 3 L33: 3.7386 L12: -1.0865 REMARK 3 L13: 1.3606 L23: -1.1508 REMARK 3 S TENSOR REMARK 3 S11: -0.1150 S12: -0.1478 S13: 0.1851 REMARK 3 S21: 0.1411 S22: 0.1163 S23: 0.3439 REMARK 3 S31: -0.5442 S32: -0.3986 S33: -0.0014 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 12.3449 -29.9892 -15.1361 REMARK 3 T TENSOR REMARK 3 T11: 0.0382 T22: -0.0976 REMARK 3 T33: -0.3040 T12: -0.1202 REMARK 3 T13: 0.0433 T23: 0.0901 REMARK 3 L TENSOR REMARK 3 L11: 2.1722 L22: 2.6879 REMARK 3 L33: 6.4054 L12: -1.0668 REMARK 3 L13: 0.9742 L23: 0.1067 REMARK 3 S TENSOR REMARK 3 S11: 0.3628 S12: 0.1761 S13: 0.1838 REMARK 3 S21: -0.1919 S22: -0.1814 S23: -0.3177 REMARK 3 S31: 0.0650 S32: 0.1058 S33: -0.1814 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6THW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1292105510. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-NOV-17 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27476 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 55.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.100 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 8.40 REMARK 200 R MERGE FOR SHELL (I) : 0.78300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: INTERNAL MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMS 0.1 M HEPES & PROTEIN BUFFER: 25 REMARK 280 MM HEPES PH 7.5, 1 MM EDTA, 1 MM TCEP, 5% GLYCEROL, 150 MM NACL, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.73500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.27000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 71.41500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.73500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.27000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 71.41500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.73500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.27000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 71.41500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.73500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.27000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.41500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 153 REMARK 465 GLU A 154 REMARK 465 ASN A 155 REMARK 465 LYS A 156 REMARK 465 SER A 157 REMARK 465 LEU A 158 REMARK 465 GLU A 159 REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 THR A 163 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 SER A 336 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 THR A 342 REMARK 465 VAL A 343 REMARK 465 MET A 344 REMARK 465 THR A 345 REMARK 465 SER A 346 REMARK 465 ARG A 347 REMARK 465 ALA A 459 REMARK 465 SER A 460 REMARK 465 GLY B 153 REMARK 465 GLU B 154 REMARK 465 ASN B 155 REMARK 465 LYS B 156 REMARK 465 SER B 157 REMARK 465 LEU B 158 REMARK 465 GLU B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 THR B 342 REMARK 465 VAL B 343 REMARK 465 MET B 344 REMARK 465 THR B 345 REMARK 465 SER B 346 REMARK 465 ARG B 347 REMARK 465 ALA B 459 REMARK 465 SER B 460 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA B 335 C - N - CA ANGL. DEV. = 19.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 206 -92.01 48.67 REMARK 500 SER A 253 104.03 63.09 REMARK 500 ASP A 254 -106.37 -76.15 REMARK 500 ASP A 256 35.60 -92.25 REMARK 500 ARG A 310 -3.20 75.47 REMARK 500 ASP A 311 50.47 -147.50 REMARK 500 ASP A 329 82.82 62.81 REMARK 500 ARG A 334 -171.08 -171.59 REMARK 500 HIS A 390 35.42 -96.48 REMARK 500 ASN B 178 62.69 61.49 REMARK 500 ASN B 206 -143.72 59.41 REMARK 500 SER B 253 15.00 -153.45 REMARK 500 ASP B 254 -74.15 -61.82 REMARK 500 ASP B 256 38.80 -70.47 REMARK 500 ARG B 310 -2.11 78.39 REMARK 500 ASP B 311 48.72 -147.00 REMARK 500 ASP B 329 81.33 72.18 REMARK 500 ALA B 335 18.19 130.27 REMARK 500 HIS B 390 36.67 -96.14 REMARK 500 LYS B 417 31.01 -82.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 668 DISTANCE = 7.14 ANGSTROMS REMARK 525 HOH A 669 DISTANCE = 7.24 ANGSTROMS REMARK 525 HOH A 670 DISTANCE = 8.83 ANGSTROMS REMARK 525 HOH B 678 DISTANCE = 6.96 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NBK A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NBK B 501 DBREF 6THW A 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 DBREF 6THW B 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 SEQADV 6THW GLY A 153 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6THW GLY B 153 UNP Q9NWZ3 EXPRESSION TAG SEQRES 1 A 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 A 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 A 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 A 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 A 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 A 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 A 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 A 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 A 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 A 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 A 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 A 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 A 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 A 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 A 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET THR SER ARG SEQRES 16 A 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 A 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 A 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 A 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 A 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 A 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 A 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 A 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 A 308 GLN LEU LEU GLN GLU MET THR ALA SER SEQRES 1 B 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 B 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 B 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 B 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 B 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 B 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 B 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 B 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 B 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 B 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 B 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 B 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 B 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 B 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 B 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET THR SER ARG SEQRES 16 B 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 B 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 B 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 B 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 B 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 B 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 B 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 B 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 B 308 GLN LEU LEU GLN GLU MET THR ALA SER HET NBK A 501 36 HET NBK B 501 36 HETNAM NBK 7-FLUORANYL-4-(1-METHYLCYCLOPROPYL)OXY-~{N}-[1-(1- HETNAM 2 NBK METHYLPIPERIDIN-4-YL)PYRAZOL-4-YL]-6-(2- HETNAM 3 NBK METHYLPYRIMIDIN-5-YL)PYRIDO[3,2-D]PYRIMIDIN-2-AMINE FORMUL 3 NBK 2(C25 H28 F N9 O) FORMUL 5 HOH *148(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 PRO A 184 GLY A 188 5 5 HELIX 3 AA3 THR A 223 CYS A 240 1 18 HELIX 4 AA4 SER A 269 SER A 275 1 7 HELIX 5 AA5 CYS A 276 THR A 280 5 5 HELIX 6 AA6 SER A 284 ASN A 305 1 22 HELIX 7 AA7 LYS A 313 ALA A 315 5 3 HELIX 8 AA8 THR A 351 MET A 355 5 5 HELIX 9 AA9 ALA A 356 ARG A 361 1 6 HELIX 10 AB1 THR A 365 GLY A 383 1 19 HELIX 11 AB2 LEU A 395 LEU A 397 5 3 HELIX 12 AB3 ASP A 398 ASP A 405 1 8 HELIX 13 AB4 THR A 409 ILE A 414 1 6 HELIX 14 AB5 ASP A 422 LEU A 437 1 16 HELIX 15 AB6 LYS A 440 ARG A 444 5 5 HELIX 16 AB7 ASP A 446 THR A 458 1 13 HELIX 17 AB8 SER B 169 THR B 177 1 9 HELIX 18 AB9 PRO B 184 GLY B 188 5 5 HELIX 19 AC1 THR B 222 CYS B 240 1 19 HELIX 20 AC2 SER B 269 SER B 275 1 7 HELIX 21 AC3 CYS B 276 THR B 280 5 5 HELIX 22 AC4 SER B 284 ASN B 305 1 22 HELIX 23 AC5 LYS B 313 ALA B 315 5 3 HELIX 24 AC6 THR B 351 MET B 355 5 5 HELIX 25 AC7 ALA B 356 ARG B 361 1 6 HELIX 26 AC8 THR B 365 GLY B 383 1 19 HELIX 27 AC9 LEU B 395 LEU B 397 5 3 HELIX 28 AD1 ASP B 398 ASP B 405 1 8 HELIX 29 AD2 THR B 409 ILE B 414 1 6 HELIX 30 AD3 ASP B 422 LEU B 437 1 16 HELIX 31 AD4 LYS B 440 ARG B 444 5 5 HELIX 32 AD5 ASP B 446 THR B 458 1 13 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 PHE A 251 1 O PHE A 251 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 208 LYS A 214 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 VAL A 199 VAL A 205 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLU A 194 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 ILE A 317 LEU A 319 0 SHEET 2 AA2 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA3 6 HIS B 166 PHE B 168 0 SHEET 2 AA3 6 LEU B 248 SER B 252 1 O PHE B 251 N PHE B 168 SHEET 3 AA3 6 CYS B 259 VAL B 263 -1 O VAL B 261 N GLY B 250 SHEET 4 AA3 6 THR B 208 LEU B 215 -1 N LYS B 213 O LEU B 260 SHEET 5 AA3 6 GLY B 198 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA3 6 LYS B 191 GLU B 194 -1 N GLY B 193 O VAL B 200 SHEET 1 AA4 2 HIS B 307 ILE B 308 0 SHEET 2 AA4 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA5 2 ILE B 317 LEU B 319 0 SHEET 2 AA5 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 CISPEP 1 ARG A 164 PHE A 165 0 -1.92 CISPEP 2 ASP A 254 GLY A 255 0 -9.74 CISPEP 3 GLU A 392 PRO A 393 0 -0.25 CISPEP 4 ARG B 334 ALA B 335 0 5.30 CISPEP 5 GLU B 392 PRO B 393 0 -0.59 SITE 1 AC1 14 MET A 192 GLY A 193 ALA A 211 LYS A 213 SITE 2 AC1 14 GLU A 233 TYR A 262 VAL A 263 TYR A 264 SITE 3 AC1 14 MET A 265 PRO A 266 GLY A 268 ARG A 273 SITE 4 AC1 14 LEU A 318 ASP A 329 SITE 1 AC2 15 ILE B 185 MET B 192 GLY B 193 ALA B 211 SITE 2 AC2 15 LYS B 213 TYR B 262 VAL B 263 TYR B 264 SITE 3 AC2 15 MET B 265 PRO B 266 GLY B 268 SER B 269 SITE 4 AC2 15 ARG B 273 LEU B 318 HOH B 614 CRYST1 87.470 110.540 142.830 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011432 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009046 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007001 0.00000